Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Nuclear Medicine

• Publication date

  2007-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 17332623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.

  2006cited by this paper
• PET of vascular endothelial growth factor receptor expression.

  2006cited by this paper
• In Vivo Near-Infrared Fluorescence Imaging of Integrin αvβ3 in an Orthotopic Glioblastoma Model

  2006cited by this paper
• In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3

  2006cited by this paper
• In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.

  2006cited by this paper
• In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.

  2006cited by this paper
• Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.

  2005influential reference
• Angiogenesis in Gliomas: Biology and Molecular Pathophysiology

  2005cited by this paper
• The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.

  2005cited by this paper
• Vascular Targeting of Ocular Neovascularization with a Vascular Endothelial Growth Factor121/Gelonin Chimeric Protein

  2005cited by this paper
• microPET Imaging of Glioma Integrin αvβ3 Expression Using 64Cu-Labeled Tetrameric RGD Peptide

  2005cited by this paper
• The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.

  2005cited by this paper
• A human transferrin-vascular endothelial growth factor (hnTf-VEGF) fusion protein containing an integrated binding site for (111)In for imaging tumor angiogenesis.

  2005cited by this paper
• Integrin alpha v beta 3-targeted imaging of lung cancer.

  2005cited by this paper
• Integrin αβ3-Targeted Imaging of Lung Cancer

  2005cited by this paper
• microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.

  2005cited by this paper
• Amplification of genes encoding KIT, PDGFRα and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme

  2005cited by this paper
• Longitudinal MicroPET Imaging of Brain Tumor Growth with F-18-labeled RGD Peptide

  2005cited by this paper
• Integrin avB3–Targeted Imaging of Lung Cancer

  2005cited by this paper
• Glioblastoma cells release factors that disrupt blood-brain barrier features

  2004cited by this paper
• Development of new drugs in angiogenesis.

  2004cited by this paper
• Volume Reconstruction Techniques Improve the Correlation Between Histological and in vivo Tumor Volume Measurements in Mouse Models of Human Gliomas

  2004cited by this paper
• Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.

  2002cited by this paper
• The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography.

  2002cited by this paper
• Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth

  2002cited by this paper
• Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.

  2002cited by this paper
• Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy

  2002cited by this paper
• Synergy between vascular targeting agents and antibody-directed therapy.

  2002cited by this paper
• In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors

  2002cited by this paper
• Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

  2002cited by this paper
• Quantitative Analysis of Varying Profiles of Hypoxia in Relation to Functional Vessels in Different Human Glioma Xenograft Lines

  2002cited by this paper
• Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET

  2001cited by this paper
• Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.

  2001cited by this paper
• Concomitant over‐expression of vascular endothelial growth factor and its receptors in pancreatic cancer

  2000cited by this paper
• PKC412--a protein kinase inhibitor with a broad therapeutic potential.

  2000cited by this paper
• VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.

  2000cited by this paper
• Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

  2000cited by this paper
• High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.

  2000cited by this paper
• In vivo modulators of antibody kinetics.

  1996cited by this paper
• Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.

  1995cited by this paper
• Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

  1994cited by this paper
• Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

  1994cited by this paper
• Vascular permeability factor (VPF, VEGF) in tumor biology

  1993cited by this paper
• Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy

  1993cited by this paper
• Brain tumors. Part 2.

  1991cited by this paper
• MEDICAL PROGRESS : BRAIN TUMORS (SECOND OF TWO PARTS)

  1991cited by this paper

• A Comprehensive Analysis of Natural Bioactive Molecules for the Treatment and Control of Glioblastoma Multiforme (GBM) Targeting Underlying Molecular Mechanism

  2025cites this paper
• Tumor Vasculature

  2021cites this paper
• The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy

  2021cites this paper
• Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas

  2021cites this paper
• Potential Limitations of Bioluminescent Xenograft Mouse Models: A Systematic Review.

  2020cites this paper
• Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors

  2020cites this paper
• PET Imaging of VEGFR with a Novel 64Cu-Labeled Peptide

  2020cites this paper
• Dual‐targeting immunoliposomes using angiopep‐2 and CD133 antibody for glioblastoma stem cells

  2018cites this paper
• VEGF in Nuclear Medicine: Clinical Applications, Future Perspectives and Review of the Literature

  2018cites this paper
• Identification of ACTG2 functions as a promoter gene in hepatocellular carcinoma cells migration and tumor metastasis.

  2017cites this paper
• Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211

  2017cites this paper
• Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential

  2017cites this paper
• Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review

  2017cites this paper
• Fms related tyrosine kinase 1 (Flt1) functions as an oncogene and regulates glioblastoma cell metastasis by regulating sonic hedgehog signaling.

  2017cites this paper
• Instrumentation challenges in multi-modality imaging

  2016cites this paper
• Growth factors, Cytokines and VEGF in human neoplastic and inflammatory pathologies

  2016cites this paper
• Estimating binding free energy of a putative growth factors EGF–VEGF complex – a computational bioanalytical study

  2016cites this paper
• A series of diphenylamine-fluorenone derivatives as potential fluorescent probes for neuroblastoma cell staining

  2016cites this paper
• MATCHING A CHELATOR (DOTA) WITH IONS FOR RADIO- PHARMACEUTICAL APPLICATIONS USING DFT STUDY

  2016cites this paper
• VEGF in nuclear medicine: Clinical application in cancer and future perspectives (Review).

  2016influential citation
• Using bioluminescence imaging in glioma research.

  2015cites this paper
• Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET

  2015cites this paper
• VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System

  2014cites this paper
• Applications of nanoparticles for brain cancer imaging and therapy.

  2014cites this paper
• Modulation, Bioinformatic Screening, and Assessment of Small Molecular Peptides Targeting the Vascular Endothelial Growth Factor Receptor

  2014cites this paper
• Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models

  2014cites this paper
• Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin.

  2014cites this paper
• Applications of Small-Animal Molecular Imaging in Drug Development

  2014cites this paper
• In vivo imaging of tumor vascular endothelial cells

  2013cites this paper
• Ligand-Based Targeting of Therapeutic and Imaging Agents for Cancer

  2013cites this paper
• Molecular Bioluminescence Imaging as a Noninvasive Tool for Monitoring Tumor Growth and Therapeutic Response to MRI-Guided Laser Ablation in a Rat Model of Hepatocellular Carcinoma

  2013cites this paper
• The Influence of Interpreters’ Professional Background and Experience on the Interpretation of Multimodality Imaging of Pulmonary Lesions Using 18F-3′-Deoxy-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT

  2013cites this paper
• Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment.

  2013cites this paper
• Imaging and Tracking Therapeutic Cells with Nanoparticles

  2013cites this paper
• Approaches in the Chemoprevention of Breast Cancer

  2013cites this paper
• New PET radiopharmaceuticals beyond FDG for brain tumor imaging.

  2012cites this paper
• Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGel.

  2012cites this paper
• Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.

  2012cites this paper
• Liposome imaging agents in personalized medicine.

  2012cites this paper
• Small Animal Imaging for Accelerating Drug Development, and Comparison to Other Techniques

  2012cites this paper
• Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging

  2012cites this paper
• Molecular Imaging with Activatable Reporter Systems

  2012cites this paper
• Polymeric Imaging Agents

  2012cites this paper
• Multimodality Imaging In Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles

  2012cites this paper
• Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.

  2012cites this paper
• Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

  2011cites this paper
• Inhibition of Prostate Cancer Osteoblastic Progression with VEGF121/rGel, a Single Agent Targeting Osteoblasts, Osteoclasts, and Tumor Neovasculature

  2011cites this paper
• Protein-based tumor molecular imaging probes

  2011cites this paper
• Multiplexed PET probes for imaging breast cancer early response to VEGF₁₂₁/rGel treatment.

  2011cites this paper
• Molecular Imaging in Tumor Angiogenesis and Relevant Drug Research

  2011cites this paper
• A novel tissue-engineered approach to problems of the postpneumonectomy space.

  2011cites this paper
• Molecular imaging in cancer treatment

  2011cites this paper
• Sensitive Angiogenesis Imaging of Orthotopic Bladder Tumors in Mice Using a Selective Magnetic Resonance Imaging Contrast Agent Containing VEGF121/rGel

  2011influential citation
• Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments.

  2011cites this paper
• Nanotechnology development and utilization: a primer for diagnostic and interventional radiologists.

  2011cites this paper
• Near-infrared Optical Imaging of Exposed Phosphatidylserine in a Mouse Glioma Model.

  2011cites this paper
• Tumor-targeted drug delivery with aptamers.

  2011cites this paper
• Positron emission tomography imaging of cancer biology: current status and future prospects.

  2011cites this paper
• Dual-Modality Monitoring of Tumor Response to Cyclophosphamide Therapy in Mice with Bioluminescence Imaging and Small-Animal Positron Emission Tomography

  2011cites this paper
• Molecular imaging of cell-based cancer immunotherapy.

  2011cites this paper
• Animal tumor models for PET in drug development

  2011cites this paper
• Can multimodality imaging using 18F-FDG/18F-FLT PET/CT benefit the diagnosis and management of patients with pulmonary lesions?

  2011cites this paper
• Biodistribution, Pharmacokinetics, and Nuclear Imaging Studies of 111In-labeled rGel/BLyS Fusion Toxin in SCID Mice Bearing B Cell Lymphoma

  2011cites this paper
• APPLICATIONS OF EPHB4 RECEPTOR SPECIFIC PEPTIDES IN TARGETED CANCER IMAGING AND THERAPY

  2011cites this paper
• Imaging in Neurology Research I: Neurooncology

  2011cites this paper
• Quantum Dots for Targeted Tumor Imaging

  2011cites this paper
• Role of Angiogenesis in the Pathogenesis of Glioblastoma and Antiangiogenic Therapies for Controlling Glioblastoma

  2010cites this paper
• Bioinorganic aspects of angiogenesis.

  2010cites this paper
• The pre-requisite of a second-generation glioma PET biomarker.

  2010cites this paper
• Mouse models in neurological disorders: applications of non-invasive imaging.

  2010cites this paper
• Bioluminescent imaging: a critical tool in pre‐clinical oncology research

  2010cites this paper
• Inorganic nanomaterials for tumor angiogenesis imaging

  2010cites this paper
• From atom to brain: applications of molecular imaging to neurosurgery.

  2010cites this paper
• Applications of molecular imaging.

  2010cites this paper
• Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

  2010cites this paper
• Early Detection of Systems Response: Molecular and Functional Imaging of Angiogenesis

  2010cites this paper
• Targeting the nucleus: an overview of Auger-electron radionuclide therapy.

  2010cites this paper
• Dynamic Near-Infrared Optical Imaging of 2-Deoxyglucose Uptake by Intracranial Glioma of Athymic Mice

  2009cites this paper
• Inhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature.

  2009cites this paper
• Techniques and software tool for 3D multimodality medical image segmentation

  2009influential citation
• Imaging targeted at tumor with (188)Re-labeled VEGF(189) exon 6-encoded peptide and effects of the transfecting truncated KDR gene in tumor-bearing nude mice.

  2009cites this paper
• Receptor-Mediated Delivery of Proteins and Peptides to Tumors

  2009cites this paper
• The coordination chemistry of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid (H4DOTA): Structural overview and analyses on structure–stability relationships

  2009cites this paper
• Development of novel, highly cytotoxic fusion constructs containing granzyme B: unique mechanisms and functions.

  2009cites this paper
• Coregistration of Ultrasonography and Magnetic Resonance Imaging with a Preliminary Investigation of the Spatial Colocalization of Vascular Endothelial Growth Factor Receptor 2 Expression and Tumor Perfusion in a Murine Tumor Model

  2009cites this paper
• Recent progress in research on ribosome inactivating proteins.

  2009cites this paper
• Applications for site-directed molecular imaging agents coupled with drug delivery potential

  2009cites this paper
• Imaging of tumor angiogenesis: functional or targeted?

  2009cites this paper
• PET Imaging of Angiogenesis.

  2009cites this paper
• Real-Time High-Resolution Compound Imaging Allows Percutaneous Initiation and Surveillance in an Orthotopic Murine Pancreatic Cancer Model

  2008cites this paper
• Diagnostic approach in suspected recurrent primary brain tumors using (18)FDG-PET/MRI, perfusion MRI, visual and quantitative analysis, and three dimensional stereotactic surface projections. First experience in Mexico.

  2008cites this paper
• Chapter 7. Molecular imaging of tumor vasculature.

  2008cites this paper
• Non-invasive assessment of tumor neovasculature: techniques and clinical applications

  2008cites this paper
• Award Number: DAMD17-03-1-0363 TITLE: Therapeutic vascular targeting and irradiation: correlation of MRI tissue changes at cellular and molecular levels to optimizing outcome PRINCIPAL INVESTIGATOR:

  2008cites this paper
• Small animal PET in preclinical studies: opportunities and challenges.

  2008cites this paper
• Determining glioma response to radiation therapy using recombinant peptides

  2008cites this paper
• Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma

  2008cites this paper
• Quantitative PET Imaging of VEGF Receptor Expression

  2008cites this paper
• In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma

  2008cites this paper
• PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development.

  2008cites this paper